Kabra Drugs
26.90
-1.23(-4.37%)
Market Cap₹63.78 Cr
PE Ratio15.54
IndustryHealthcare
Company Performance:
1D-4.37%
1M-18.88%
6M+39.38%
1Y+142.78%
5Y+527.04%
View Company Insightsright
More news about Kabra Drugs
24Sept 25
Kabra Drugs to Finalize Acquisition of AMR Pharma India in Upcoming Board Meeting
Kabra Drugs Limited has scheduled a board meeting for October 8, 2025, to discuss key strategic moves. The agenda includes approving the Share Purchase Agreement for acquiring AMR PHARMA INDIA PRIVATE LIMITED, expanding the board with new technical personnel, and authorizing steps to execute the acquisition transaction. This meeting signals potential growth and enhanced expertise for the pharmaceutical company.
 no imag found
06Aug 25
Kabra Drugs Limited Diversifies into Medical Equipment, Establishes Chennai Office
Kabra Drugs Limited's Board of Directors has approved diversification into the medical equipment and medical instruments sector. The company will establish a new office in Chennai at Cactus Corporate Coworking, Tecci Park, to support this venture. The decision was made during a board meeting on August 6, 2025, from 6:00 PM to 7:00 PM (IST). This move represents a significant expansion of Kabra Drugs' business operations beyond pharmaceuticals.
 no imag found
Kabra Drugs
26.90
-1.23
(-4.37%)
1 Year Returns:+142.78%
Industry Peers
Sun Pharmaceutical
1,744.40
(-1.91%)
Divis Laboratories
5,972.50
(-2.73%)
Torrent Pharmaceuticals
4,210.80
(-1.83%)
Dr Reddys Laboratories
1,274.50
(-1.57%)
Lupin
2,251.50
(-2.21%)
Cipla
1,239.20
(-2.31%)
Zydus Life Science
876.15
(-2.61%)
Mankind Pharma
2,000.80
(-4.86%)
Aurobindo Pharma
1,247.50
(-1.69%)
Alkem Laboratories
5,240.00
(-2.08%)